Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (54)	1/1/2011 5:28:06 PM
From: technetium	2 Recommendations Respond to of 400

Ditto. These are this year's rules (8 versus 6). Toss in two more at 5% each. Won't hurt overall performance much and is an interesting way to stretch your imagination. (Err, develop a new area of expertise to research thoroughly.) OT, IIRC, it concerns some that the new DSM-V, which defines what is a psychological/drug-able "disease" (i.e., open for medical insurance coverage) now includes “psychosis risk syndrome” in children or young adults, which opens the doors wide for whichever company has the magic pill and sales force to cure all ills before they happen. Cynical view: Who stands to benefit most from this change? drvitelli.typepad.com "... fundamental questions remain concerning the ethical consequences of false positives as well as how soon biomedical interventions should begin... If prodromal patients never progress to full-blown psychosis, would they be able to live normal lives without the stigma..."

To: IRWIN JAMES FRANKEL who wrote (54)	1/2/2011 1:46:09 PM
From: mopgcw	Respond to of 400

i agree, we can go to a six minimum next year if that is the consensus. personally, I like the 8 minimum.

To: IRWIN JAMES FRANKEL who wrote (54)	1/2/2011 10:11:17 PM
From: ghmm	Respond to of 400

This sounds reasonable to me. Perhaps (I suspect unacceptable) way around this for someone wanting to pick less then 8 could be to stack their picks by picking something like CYPB which is in a buyout? I think this is for charity so I don't have a problem with someone doing that (even if it gives them a bit of an overloaded portfolio), nor do I have a problem with someone picking pharma or even a device company for that matter... maybe because I did that once :-) (and did badly with it).